Description
SAMPLE TYPE: BLOOD
Requires venous extraction
RESULTS: 20 DAYS
Results delivered from sample reception
The GNT. Celiac Disease (Gluten Intolerance) analyzes the genetic variants associated with celiac disease, an autoimmune pathology that causes permanent gluten intolerance. This disease has a significant hereditary component (between 7.5% and 15%), and its genetic diagnosis allows the identification of predisposition even before the onset of symptoms. The study focuses on the alleles of the HLA-DQA1 and HLA-DQB1 genes, fundamental genetic markers for determining susceptibility to celiac disease. A positive result indicates a genetic predisposition, while the absence of these risk alleles rules out the probability of developing it by 95%.
Its objective is to determine the genetic predisposition to celiac disease and differentiate it from non-celiac gluten sensitivity, facilitating a more precise diagnosis and appropriate nutritional intervention.
Performing this test requires a medical prescription. The requesting healthcare professional must ensure that the patient receives appropriate genetic information and counseling, as well as the correct clinical interpretation of the results.
- People with chronic digestive symptoms or symptoms related to gluten intake (abdominal pain, diarrhea, distension, fatigue).
- First-degree relatives of patients with celiac disease.
- Patients with doubtful serological results or biopsies.
- Children or adults with associated autoimmune diseases (thyroiditis, type 1 diabetes, dermatitis herpetiformis).
Risk haplotypes HLA DQA1 and DQB1: DQ2 (2.2 and 2.5), DQ7.5, DQ8 and DQX (2.x, x.2 and x.5)
For more information, contact the Teletest administration department at 932 12 33 45 or through the following form

BUDGETS
ACCESS TO YOUR TESTS
MY RESULTS
PROFESSIONAL ACCESS
